Cipremi for COVID-Treatment: Cipla Cipremi price under Rs 5,000 dosage remdesivir COVID-19 drug Covifor Fabiflu

Image Source : FILE Cipremi: Cipla to price remdesivir version for COVID-19 drug under Rs 5,000 Mumbai-based drugmaker Cipla on Tuesday announced that it will price ‘Cipremi’, its generic version of Gilead Sciences Inc’s antiviral drug remdesivir for use in Covid-19 patients, at less than ₹5,000 ($66) per 100mg vial. …

Read More Cipremi for COVID-Treatment: Cipla Cipremi price under Rs 5,000 dosage remdesivir COVID-19 drug Covifor Fabiflu